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Abstract
Bicuspid Aortic Valve (BAV) is a highly heritable congenital heart defect. The low frequency of BAV (1% of general
population) limits our ability to perform genome-wide association studies. We present the application of four a priori SNP
selection techniques, reducing the multiple-testing penalty by restricting analysis to SNPs relevant to BAV in a genome-wide
SNP dataset from a cohort of 68 BAV probands and 830 control subjects. Two knowledge-based approaches, CANDID and
STRING, were used to systematically identify BAV genes, and their SNPs, from the published literature, microarray expression
studies and a genome scan. We additionally tested Functionally Interpolating SNPs (fitSNPs) present on the array; the fourth
consisted of SNPs selected by Random Forests, a machine learning approach. These approaches reduced the multiple
testing penalty by lowering the fraction of the genome probed to 0.19% of the total, while increasing the likelihood of
studying SNPs within relevant BAV genes and pathways. Three loci were identified by CANDID, STRING, and fitSNPS. A
haplotype within the AXIN1-PDIA2 locus (p-value of 2.926610
206) and a haplotype within the Endoglin gene (p-value of
5.881610
204) were found to be strongly associated with BAV. The Random Forests approach identified a SNP on
chromosome 3 in association with BAV (p-value 5.061610
206). The results presented here support an important role for
genetic variants in BAV and provide support for additional studies in well-powered cohorts. Further, these studies
demonstrate that leveraging existing expression and genomic data in the context of GWAS studies can identify biologically
relevant genes and pathways associated with a congenital heart defect.
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Introduction
The aortic valve, as formed during embryonic heart develop-
ment, is comprised of three cusps divided by three commissures.
Cusp fusion, or the failure of the cusps to separate during heart
development, can produce a valve with two cusps (bicuspid) or one
cusp (unicuspid) [1]. In a bicuspid valve, the two conjoined cusps
form a larger cusp that operates with the remaining, normal cusp
to perform the valve function [2]. While the prevalence of BAV is
approximately one percent of live births (13.7 per 1,000), one third
of the aortic valves replaced are found to be bicuspid at the time of
valve replacement [3]. Thoracic ascending aortic aneurysms
(TAA) are also found in patients with BAV, sometimes even in
pre-teen children.
Consistent with a strong genetic predisposition the heritability
estimates of BAV range from 0.75 to 0.89 [4]. Studies conducted
in 13 families with BAV suggest that BAV and TAA are
independent manifestations of a single underlying gene defect
with incomplete penetrance [5,6]. NOTCH1 mutations have been
found in sporadic cases of BAV [7,8]; however, a consistent role
for NOTCH1 gene variants in BAV has not been found [9].
Despite a high heritability, challenges remain in determining the
genetic cause of BAV. First, few multigenerational pedigrees
contain BAV as an isolated trait to enable gene identification by
traditional approaches. Second, large, well phenotyped BAV
cohorts are not readily available due to the relative rarity of BAV
in the general population. Third, it can be difficult to determine
non-invasively whether a thickened and calcified aortic valve is
bicuspid or tricuspid in adults; direct, surgical inspection is often
required to determine whether a BAV is present, which limits
subject recruitment. Finally, the phenotypic diversity observed
within BAV implies an assortment of developmental pathways
ultimately converging around a single, uniquely identifiable
phenotypic outcome: aortic valve formation and valve disease.
Due to the complexity of the developmental processes that
contribute to heart valve formation and valve disease, candidate
gene approaches are unlikely to identify the genetic determinants
of BAV. The application of a broader form of analysis is needed to
identify the complex genomic contributors to BAV in an unbiased
manner. Traditional genome-wide association study (GWAS)
approaches have identified genes that contribute to common
diseases including coronary artery disease [10,11]. GWAS studies
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related genes for highly heritable disorders such as age-dependent
macular degeneration [12]. With the addition of haplotype-based
analyses, a wide spectrum of observed variant frequencies can be
useful with regard to analysis of both common, complex disorders
as well as highly heritable but relatively rare disorders (such as
BAV) [13,14]. While an unbiased approach offers significant
potential for discovery of single, potent, highly penetrant genetic
determinants of BAV, the multiple-testing load inherent to this
approach weakens our ability to detect important associations. To
control for random associations, generated p-values typically must
reach ‘‘genomic’’ levels [15], and adopting such stringent
standards is likely at the expense of weak but biologically plausible
associations, especially in settings with obligate limitations to
sample sizes.
These limitations have led to the development of two primary
strategies for applying gene network-based analysis to genome-
wide SNP datasets. The first, a knowledge-based approach,
leverages existing annotations, public expression data, previously
published associated genes or chromosomal regions, and any other
quantifiable information that has been the output of directed
study. These data are computationally combined into interaction
pathways that extend from the input genes, genomic regions, and
specific protein/protein interactions into the broader pathways
that these elements inhabit [16–18]. Thus, starting from lists of the
most differentially expressed genes within a trait, the multiple gene
partners, alternate transcripts, functionally similar genes, con-
served structural motifs or sequences, and any other quantifiable
aspect of a protein or gene region can be added, allowing for the
construction of a gene network relevant to the underlying disorder
in question. This final list of network genes forms a prioritized list
from which available probes located within these genes (or the
regulatory regions surrounding them) are selected for association
analysis [19]. A related approach, employed by tools such as
Endeavour [20], assumes a robustly defined set of ‘‘known genes’’
that make up a phenotypic signature, usually based on expression
data. Endeavour applies many annotation categories and a text-
based search to find genes with signatures similar to the training
set, returning a rated list of genes for future study that should
inform and extend the ‘‘known’’ training set. While this approach
is quite powerful, it presupposes a well-understood and robustly
described starting point in the form of a training set. The complex
genetic data, much of it poorly understood or contradictory, that
currently describes BAV implies the need for more inclusive initial
approaches that start from the various known genes but extend
from there, including while broadening what is known to also
include what is likely.
The second type of analysis, a machine learning approach,
leverages the ability of multiply partitioned datasets to select a
subset of SNPs within the overall set of available probes most likely
to be informative at defining the phenotype in question [21,22].
Here we describe the application of these two strategies to the
analysis of a genome-wide SNP dataset for BAV. Furthermore, we
characterize the effects of using differing techniques within these
strategies on the outputted association results. Specifically, we
examine STRING[16] and CANDID [17], competing knowledge-
based methods for forming genetic and protein interaction
networks. We also apply two other approaches to forming an ab
initio list of SNPs likely to have high information content: fitSNPs
and Random Forests. FitSNPs are a collection of variants gleaned
from exhaustive searches of public expression data and are highly
likely to be functionally relevant SNPs (but are not associated with
a specific disease or phenotype). Random Forests are included as
an unbiased probeset, selected by perceived information content of
the included SNPs relative to their capability to partition our
dataset relative to trait (e.g. BAV). We hypothesize that collections
of SNPs selected by multiple probe prioritization strategies within
haplotype blocks strongly associated with BAV will help identify
genes relevant to this disorder. The product of these studies offers
a comprehensive analysis of a limited cohort while still respecting
the rules of multiple testing.
Results
BAV Cohort
We collected DNA from 68 probands found to have BAV by
direct visualization at the time of aortic valve replacement or by
echocardiography. The average age of BAV Genetics Study
participants at the time of enrollment was 53 years (range 18 to
85), and the majority of subjects were men (54 of 66).
Echocardiography demonstrated normal aortic valve function in
18 subjects, moderate to severe aortic valve stenosis was detected
in 38 subjects, and three subjects had isolated severe aortic valve
regurgitation. We included six subjects that had coarctation of the
aorta (all repaired) and 19 who had TAA (17 repaired) in our
cohort since the BAV-associated aortic phenotypes are considered
to be independent manifestations of a single underlying gene
defect with incomplete penetrance (5). Genomic DNA from these
individuals was genotyped on the Illumina 370CNV array.
Additionally, genotypes for 823 control individuals were obtained
from Illumina iControlDB [23] and joined seven BAV-negative
familial controls present in our dataset for a total of 830 individuals
in the control cohort. After excluding the copy number probes
(which are not represented in the Illumina-supplied control
population), the dataset included 311,399 probes. The prevalence
of BAV in the general population would suggest that only ,1% of
the control cohort would have a BAV. There was no evidence of
significant population structure in the combined control/experi-
mental group [24].
Sources of Biological Knowledge for Our Initial Analysis
Several sources of information served as the basis for our
network analysis. First, we selected MeSH terms (including
OMIM headings) that characterize BAV and its associated
syndromes. Second, we identified genes differentially expressed
in the aorta of subjects with BAV compared with a normal
tricuspid aortic valve (TAV) from the Gene Expression Omnibus
(GEO) dataset GDS2922.[25] Analysis of these arrays was carried
out by both parametric (limma) and non-parametric (RankProd)
methods. These two approaches predominantly selected different
gene-sets relative to observed expression levels in experimental
(BAV, TAA) versus control (TAV, TAA) patients. Combining the
output from the parametric and non-parametric array analyses
resulted in a collection of 1,552 differentially expressed genes
(limma n=903, RankProd n=649) that broadly mirrored
previous findings from the datasets in question but were
necessarily more inclusive. Gene ontology analysis showed a
broad representation from across the functional spectrum with
specific ontologic classes, such as coagulation and inflammatory
response, metabolism, development, and cell communication (see
Table S1). Third, we included the most significantly altered genes
(n=41) detected in the peripheral blood of patients with TAA
compared with normal individuals (GSE9106).[26] Finally, we
included chromosomal loci linked with BAV by microsatellite-
based study [9,27]. Through our primary analysis of microarray
data and the selection of all published and genomic loci we
constructed a knowledgebase for BAV to serve as a basis for the
construction of an overall BAV-related gene network.
BAV Genetics
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We combined the multiple sources of biological knowledge,
including the RankProd and limma analyses, to create parallel
interaction networks relevant to BAV using STRING [16] and
CANDID [17] (Figure 1). Table 1 describes the commonalities
and differences of the SNPs selected by these two programs.
STRING took the outputs of the limma and RankProd expression
analyses and created substantially different output networks,
reflecting the nature of the input, with RankProd ultimately
generating a gene list composed of 6,651 prioritized SNPs, and
limma 3,970 SNPs. An additional 694 probes were shared
between methods. CANDID, alternatively, produced highly
similar lists from the same limma and RankProd inputs, ultimately
differing at only 155 out of 13,769 selected SNPs.
Separately, we identified the 8,801 Functionally Interpolating
SNPs (fitSNPs) present on the Illumina 370CNV array. FitSNPs
were derived through extensive analysis of public array datasets
[28]. While not selected relative to specific disease or expression
outcome, fitSNPs represent a set of markers enriched for
functionally relevant variants (e.g. non-synonymous coding region
polymorphisms) from across the genome.
From the 370CNV array, 1532 probes were selected both by
CANDID (12% of all CANDID SNPs) and by STRING(15% of all
STRING SNPs). The fitSNPs overlapped CANDID at 554 probes
(4.4%) and STRING at 543 probes (6.2%). 97 SNPs were selected
by these three approaches (CANDID, STRING and fitSNPs). Full
comparisons between probes selected by CANDID, STRING,
Random Forests, and fitSNPs are shown in Tables 1 and 2.
We considered genes identified by more than one strategy to
have the greatest potential for a role in BAV. To test this
hypothesis we determined the association of each prioritized SNP
for differentiating case (BAV) from control status. When we
compared the top 100 SNPs (by p-value) from each strategy, three
chromosomal regions were selected by all three strategies: AXIN1-
PDIA2, ENG, and BAT2-BAT3.
AXIN1-PDIA2 Haplotype Is Associated with BAV
STRING, CANDID and FitSNPs identified a concentration of
SNPs in chromosome 16p13.3 within a region that includes AXIN1
and PDIA2. AXIN1 was selected by CANDID and STRING
because its expression in aorta from subjects with BAV compared
with TAV was significantly different by limma (adjusted p-value of
3.79610
249).FourSNPsselectedbyall threeapproacheswithinthis
region (Figure 2) showed associations with BAV that did not surpass
correction for multiple testing (Figures 2 and 3). There was
significant linkage disequilibrium observed in the locus suggesting a
haplotype block structure. Eleven haplotypes derived from nine
AXIN1-PDIA2 region SNPs (Figure 4) were identified in this
region. The observed block structure in our case-control cohort
recapitulates that observed by the relevant European HapMap data
[29]. The TTGGGGTAT haplotype showed the strongest
Figure 1. Schematic Representation of SNP Prioritization. The
311,399 SNPs present on the Illumina CNV370 (representing about
15,000 well annotated genes) are prioritized by three methods. The
‘‘knowledge-based’’ approach involves expression analysis and inclu-
sion of existing annotations, term extension by CANDID or STRING
network-based analysis, and ultimately leading to the output of a gene
list. Probes inside and within regulatory regions of these genes are then
selected for association analysis. Probe results for the STRING arm are
shown as an example: 8,801 SNPs representing approximately 815
prioritized genes. In parallel, SNPs are prioritized by Random Forest
analysis, which recursively partitions the data to reveal SNPs with
highest likelihood of successful association results. Finally, fitSNPs
(derived independently of this study) represented on the CNV370 array
are analyzed for association.
doi:10.1371/journal.pone.0008830.g001
Table 1. Prioritized Probe distribution by category.
Sub-Class CANDID STRING
limma only 94 2960
RankProd only 61 5200
limma/RankProd 12,405 641
Total SNPs 12560 8801
Random Forests 222 180
fitSNPs 554 543
STRING/CANDID 1397 1397
RF and fitSNP categories in italics represent shared probes from those
respective classes; STRING/CANDID row presents STRING probes in common
with CANDID and vice versa.
doi:10.1371/journal.pone.0008830.t001
Table 2. ab initio Probe distribution by category: Categories
in italics represent shared probes from those respective
classes.
Sub-Class fitSNPs Random Forests
Random Forests 123 6322
fitSNPs 8100 123
Prioritized 1097 402
doi:10.1371/journal.pone.0008830.t002
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multiple testing (p-value 2.926610
26, OR 3.978). Further narrow-
ing or widening of this window reduced the association of the locus,
strongly implying that variants within this regional block unit are
associated to the BAV phenotype.
Haplotype analysis was unable to discriminate whether the
variants inAXIN1orPDIA2weredrivingtheassociation with BAV
in this gene-rich region. Indeed, SNPs observed within PDIA2 are
in high LD with SNPs in AXIN1 regulatory regions and vice-versa.
However, the three SNPs with the strongest individual association
with BAV are all non-synonymous polymorphisms of PDIA2: -
T286M (rs2685127), -K185E (rs419949) and –Q388R (rs400037);
of these, rs419949 lies outside the most strongly associated
haplotype. These results suggest that the co-occurrence of two of
these three PDIA2 protein-coding changes is associated with
increased odds of BAV. However, as the bulk of the haplotype
resides in AXIN1, a gene in a pathway relevant to heart valve
formation,[30] we cannot exclude a role for a primary genetic
variant located in either PDIA2, AXIN1, or both as contributing to
theobservedassociationwithBAV.However,therearecurrentlyno
additionalknown,non-synonymouscodingSNPslocatedwithinthis
region beyond those represented in the collected genotypes.
Endoglin (ENG) Haplotype Is Associated with BAV
SNPs within the gene endoglin (ENG) were prioritized for
analysis by STRING, CANDID, and FitSNPs. ENG was initially
selected for inclusion by RankProd analysis that found differential
expression in aortic aneurismal tissue from patients with BAV
compared with TAV (GDS2922). Haplotype analysis identified one
block including a conservative coding region variant (ENG-T343T,
rs3739817) associated with BAV (p-value 5.88610
204, OR 2.79)
(Figure 5). ENG-T343T (rs3739817) appears to be the critical SNP
within the haplotype, as presence of the minor allele at this locus
segregateswithBAV acrosstheregion.Thoughthepredictedamino
acid change is synonymous (T/T), recent work suggests that even
conservative alterations may yield functionally unique outcomes
[31]. The possibility also exists for a novel, causative variation in
high LD with this haplotype/SNP not present in our analysis; no
known variants of this type are present within the region.
Additional Loci
The BAT2/3 locus is located at chromosome 6, and two
haplotypes in this region are each weakly associated with BAV
(Table S2). However, detailed analysis of this haplotype fails to
show a single, clear association with trait. Similarly, the remaining
repeated-hit loci at MYLK, LEF1, CSF1R, REXO4, CD44,
ZBTB16, and FBNL1, though containing associated SNPs, do not
return a single associated haplotype that spans the region of
interest, typically due to low probe counts, very large regions, or
low frequency of the putative associated haplotypes within our
population. While these loci may be significant in BAV, further
study is required to fully clarify the location and identity of
causative variant(s) that may be within these regions.
Random Forests Analysis
As a complementary strategy that is not dependent on existing
knowledge we performed a Random Forests analysis to select
SNPs from our genome-wide dataset with the greatest information
content. Starting with 267,196 SNPs Random Forests analysis
yielded an analysis group of 6,322 SNPs, approximately equal in
dimension to that used by the supervised approaches. Fewer than
five percent of the SNPs selected by Random Forests were also
selected by either CANDID, STRING or fitSNPs (Table 1).
Association analysis identified one SNP associated with BAV
(rs388647, OR 4.562, p=0.03201 following correction for
multiple testing) located on chromosome 3 within the RefSeq
transcript zinc finger protein 385D (ZNF385D; NM_024697.1).
Low probe density in this region on the Illumina 370CNV array
(there are only two other probes located within 5 kb of the
associated SNP) prevents a more detailed haplotype analysis.
However, the associated SNP and its two nearest neighbors form a
stable haplotype that spans an exon (Figure 6).
Comparison of the Four Gene/SNP Selection Strategies
We compared the top SNPs selected by the four gene/SNP
selection strategies (Table S3). Each selection strategy picked a
different top SNP. CANDID selected the SNP with the strongest
BAV association (rs9930956).
Figure 2. Frequent Placement in Top 100 uncorrected p-Values sorted by chromosome; SNPs appearing two or more times
amongst the three categories. C=CANDID, S=STRING, F=fitSNP. Red=present in top 100, blue=not present in top 100. Remaining fields
are Gene symbol, Ensembl-51 consequence type, Odds Ratio, and unadjusted p-Value for each reported SNP.
doi:10.1371/journal.pone.0008830.g002
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These results demonstrate that mining existing published
literature, expression, and genome scan data in a systematic
manner can identify biologically plausible genes and pathways that
have variants significantly associated with BAV, ultimately a
disease of early development. Because we describe a single cohort,
we consider the results to be hypothesis generating. The successful
identification of candidate SNPs/genes by our prioritization
analyses now provides motivation for the collection and testing
of additional cohorts for independent analysis.
Molecular pathways that regulate the cellular components of the
developing heart valve have been identified [32]. In particular,
cells derived from the cardiac neural crest are critical cellular
constituents of the developing aortic valve and the great vessels
[33]; defects within cardiac neural crest development have been
Figure 3. BAV Associated Haplotype Spanning PDIA2 and AXIN1. Data from three approaches and relevant genomic features extracted from
the Ensembl 54 database are depicted. At the top of the plot is an ideogram depicting a location on chromosome 16; the small red box delimits a
region between base pair 212416 and 407490, displayed immediately below the ideogram (track labeled ‘‘bp’’ which also indicates the 59 to 39
orientation of the plot). Annotated gene content is displayed on positive (denoted by ‘‘+’’) and negative (denoted by ‘‘2’’) strand. The four graphical
data-panes indicate RR cM/Mb: relative recombination rate in centimorgans per megabase as derived from HapMap build 36. STRING 2log(p),
CANDID 2log(p), and fitSNPs 2log(p): 2log10 uncorrected p-values observed in each of the three indicated schemes. All probes analyzed in the
region by each respective schema are represented by a peak. The region between the two tallest peaks in the STRING and CANDID plots delineates
the observed haplotype detailed in Figure 4.
doi:10.1371/journal.pone.0008830.g003
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signaling pathway component important for the cardiac valve
formation [32], have been found to cause complex congenital
heart defects including BAV [35] and have also been associated
with BAV in the context of aneurysm [36]. We did not find that
SNPs within NOTCH1 are associated with BAV in our cohort.
However, we did identify BAV-associated genes that lie within
networks that contribute to valve formation and include
NOTCH1. Taken together with previous published findings [8],
our results suggest that genetic derangement of pathways that
contribute to valve formation underlie formation of a BAV.
A locus containing AXIN1 and PDIA2 was retained by all
methods, and haplotype analysis revealed a strong association
with BAV (Figure 3). AXIN1 (AXis INhibitor 1) is a critical
memberofthe Wnt pathway, which is one signaling pathway that
regulates both heart valve formation [32] and cardiac neural
crest development [37]. In addition to the Wnt pathway, AXIN1
influences signaling by the transforming growth factor beta
(TGFb) family [38], which is also a key regulator in the cardiac
neural crest [39]. When the individual AXIN1-PDIA2 SNPs
were combined into a region-spanning locus, significant associ-
ation with trait is strong and consistent with the overall
independent findings (Figure 2 and Figure 3). The three most
associated SNPs are in medium to high linkage disequilibrium
with each other, and reconstructing haplotypes across this region
functions to segregate affected from unaffected individuals. The
presence of two Protein Disulfide Isomerase family A, member 2
(PDIA2) peptide modifying SNPs in the first two positions of this
haplotype (Figure 3) provides a compelling potential functional
mechanism. It is difficult to speculate the potential role for the
P D I A 2c o d i n gS N P si nB A V ,a st h er o l eo fP D I A 2i nh e a r tv a l v e
formation is not known. It is worth noting that each of the
haplotypes containing one of these two shifts is at least
moderately significant relative to the trait. Further genotyping
is required to determine the relative contribution of AXIN1 and
P D I A 2v a r i a n t st oB A V .
Endoglin (ENG), as summarized in Figure 5, represents an
instance in which a minor allele resulting in a conservative peptide
shift is observed in the only haplotype associated with trait
(Figure 5). Recently, there has been an appreciation that
synonymous coding region polymorphisms can have a significant
effect through alterations of translational efficiency and the
secondary structure of the transcript [31]. In humans, ENG is
expressed in heart valves and the aorta [40] and its expression is
increased in endocardial cushion mesenchyme during valve
formation [41]. ENG is required for differentiation of neural crest
cells into the smooth muscle cells that populate the aorta [42], and
knockout mice heterozygous for ENG deletion show a tendency
towards aneurism formation [43]. The durable haplotype
association observed at this locus is particularly interesting because
defects in NOTCH signaling, which are associated with BAV
[7,8], have defective basement membrane around the early aorta
and show down-regulation of ENG [44]. The identification of a
haplotype of ENG, a gene known to be important in heart valve
formation, being associated with BAV illustrates the potential for
strategies centered on networks and systems biology to identify
Figure 4. Haplotype Analysis for PDIA2 and AXIN1. ‘‘|’’ indicates haplotype grouped with one above it. Numbers in parenthesis represent 95%
confidence interval. OR (A) and OR (U) abbreviate Odds Ratio Affected and Unaffected, respectively. Freq A, U, and P observed haplotype frequency
Affected, Unaffected, and Population (control and experimental, this study); PS=Peptide Shift, italics bases within haplotype signify presence of
peptide-shifting variant.
doi:10.1371/journal.pone.0008830.g004
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would likely have otherwise been overlooked by traditional GWAS
analysis.
SNP selection by Random Forest returned different markers
than the two knowledge-based strategies. It must be noted that
computational limitations ultimately affect how many forests could
be grown for our analysis, even in the context of our relatively
small population with several hundred thousand probes. The
modified RandomJungle approach [45] appears to deal specifi-
cally with this limitation, and we anticipate investigating its utility
in studies like those that we report here. We consider our
identification of a SNP in chromosome 3 associated with BAV to
be hypothesis generating pending replication in independent
cohorts because the SNP occurs in a relatively low-probe-density
region and the marginal significance of the null-model haplotype
weakens the likelihood of overall locus significance. While further
analysis is needed to establish the durability of this isolated
observation, the presence of a strong haplotype across a coding
region implies a potential functional outcome, the biological
impact of which remains uncertain.
Probe prioritization in our case offered at least an order of
magnitude of multiple-testing relief. In the case of the CANDID
probe collection (which employs the largest number of probes of
any set used in this study) the probe prioritization process reduced
the fraction of the genome analyzed to 0.19% of the total. This
directed specificity is not reflected in current, overly strict
correction methodology. Further complications emerge in the
apparent genetic heterogeneity underlying the singular phenotype
of BAV. While several apparently causative defects have been
identified in isolated families, the broader spectrum of BAV has
been difficult to characterize genetically [9,4,5]. We hypothesize
that any cohort of BAV individuals is likely to be a mixed
representation of various possible BAV-causing developmental
defects, further eroding the capability of small cohorts to describe
the condition fully at the genetic level. We describe a method for
prioritization of specific SNPs that both directly addressed these
potential issues and successfully identified biologically plausible
genomic loci associated with BAV. The identification of genes with
known biological roles in heart valve formation (AXIN1 and ENG)
and additionally within pathways and regulatory networks
Figure 5. Haplotype Analysis for ENG. ‘‘|’’ indicates haplotype grouped with one above it. Numbers in parenthesis represent 95% confidence
interval. OR (A) and OR (U) abbreviate Odds Ratio Affected and Unaffected, respectively. Freq A, U, and P observed haplotype frequency Affected,
Unaffected, and Population (control and experimental, this study); PS=Peptide Shift (in this case a conservative instance), italics bases within
haplotype signify presence of peptide-shifting variant.
doi:10.1371/journal.pone.0008830.g005
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strates the power of association testing that incorporates biological
knowledge. The findings presented here highlight the need for
collection and analysis of a large BAV cohort powered for a fully
unbiased analysis and showcases the power that gene-based and
network-based analyses can supply for analyzing complex but
heritable genetic systems.
Materials and Methods
Cohort
The Tufts Medical Center/Tufts University Institutional
Review Board approved all studies and study procedures followed
signed participant informed consent in accordance with the
principles expressed in the Declaration of Helsinki. Probands
were identified by the discovery of a bicuspid aortic valve at the
time of aortic valve replacement or defined by echocardiography,
agreed upon by two separate readers. The average age of BAV
Genetics Study participants at the time of study entry was 53
years (range 18 to 85), and the majority of subjects are men (54 of
66). Among the 66 subjects with a BAV, six also had coarctation
of the aorta (all repaired) and 19 were found to have an aneurysm
of the ascending aorta (17 repaired). Echocardiography demon-
strated normal valve function of the BAV in 18 subjects.
Moderate to severe aortic valve stenosis was detected in 38
subjects; three subjects had isolated severe aortic valve regurgi-
tation. Genomic DNA was genotyped on the Illumina 370CNV
array by deCode (Reykjavik, Iceland). Genotypes for 823 control
individuals (average age 43, range 30 to 88) were obtained from
Illumina iControlDB [23]. These individuals are genotyped on
the same platform as our experimental study was with the
exception of copy number probes present on the 370CNV array
variant that were not included in the control population study; all
non-overlapping probes were set to missing for the purposes of
this study. When these individuals were added to the handful of
familial cases and controls (a total of five cases (,7%) exhibit
family history of BAV) already in our population, 830 control
individuals were available for use in the analysis. Using the
software package Structure and the standard methodology
described by Pritchard et al. [24], we employed 25,000
independent simulations to model the number of potential sub-
populations (K) present in our case/control cohort. The smallest
value of K that appeared to describe the cohort was 3. Values of K
from 0 to 8 were analyzed for their consistency. These analyses
returned no evidence of significant allele frequency divergence at
any value of K within the control and experimental groups when
considered singly or as a whole.
Power to Detect Associations
Using the Genetic Power Calculator for discrete traits [46], we
determined that, with our cohort dimensions and a 1%
population prevalence of BAV, power to detect at a significant
association in our cohort would reach 80% at observed odds
ratios greater than 2. Odds ratios of 4 or greater (as observed in
the AXIN1 haplotype, Figure 4) reach similar power with 53
individuals. By comparison, the various BAV sub-phenotypes
present in our cohort each represent fewer than 18 individuals,
far fewer than are required to reach any reasonable power
threshold; these sub-phenotypes were therefore excluded from
further analyses.
DNA
Collection of DNA from subjects with a BAV, and some of their
family members, began February 2006. Cases were identified at
the time of aortic valve replacement by direct surgical observation
or from an echocardiogram performed for evaluation of the aortic
valve. Blood is collected in PaxGene DNA tubes (Qiagen) and the
DNA is purified using a dedicated purification kit. The
concentration of DNA in each sample is measured using the
PicoGreen assay (Invitrogen).
Figure 6. Haplotype Analysis for ZNF385D. ‘‘|’’ indicates haplotype grouped with one above it. Numbers in parenthesis represent 95%
confidence interval. OR (A) and OR (U) abbreviate Odds Ratio Affected and Unaffected, respectively. Freq A, U, and P observed haplotype frequency
Affected, Unaffected, and Population (control and experimental, this study); PS=Peptide Shift (in this case a conservative instance), italics bases
within haplotype signify presence of peptide-shifting variant.
doi:10.1371/journal.pone.0008830.g006
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1) Generation of the initial phenotype descriptor. Using Cytoscape’s
Agilent Literature Search plug-in [47], we employed a list of
twenty broadly topical MeSH keywords to describe each of the
major categories and outcomes of BAV and BAV-associated
syndromes (the complete list is available in Supplemental
Methods). Additionally, we added various gene-specific descrip-
tors, such as ‘‘NOTCH,’’ to ensure full coverage of previously
described BAV genetic profiles. We also included information
garnered from microsatellite analysis of BAV individuals, which
had identified several discrete regions of the genome thought to be
involved in the development of BAV [27]. These core terms
produced a basic protein interaction network consisting of 124
proteins (and genomic locations). 2) Addition of prioritized genes:W e
analyzed GDS2922 and GSE9106 separately using limma [48]
and RankProd [49] applying default settings within the statistical
analysis program R [50]. 3) STRING and CANDID analysis:T o
integrate and extend the RankProd and limma generated gene lists
with the initial phenotype descriptor network we employed
STRING and CANDID.
STRING and CANDID network integration. The
intention of using dual approaches being to capture both
broadly modified genes between classes as well as those genes
that vary within classes while maintaining an overall differential
expression level between the two groups. With regard to STRING,
networks were formed with a maximum of 4 additional inter-
member nodes, a ‘‘medium’’ confidence score of 0.4, no more
than 50 interactors shown, an edge scaling of 80%, and all Active
Prediction Methods selected. CANDID allows for more nuanced
subscoring of various components. All components were weighted
equally, with the exception of ‘‘Conservation,’’ which was given
the lesser weight of 2 relative to the rest of the entries. Tissue codes
44 (heart) and 53 (cardiac myocytes) were employed.
In all cases, output of proteins and their interactors were
converted into genomic regions of origin by employing the UCSC
Genome Table Browser, employing Ensembl Gene codes (ENSG)
to capture various potential transcripts that may arise from a single
‘‘gene.’’ Additionally, a buffer region of 5 kb was added to the
beginning and end of each expression region to allow for upstream
or downstream control elements potentially present. These regions
in hand, the intersection of CNV370 probes falling within the
various regions were calculated. The number of SNPs corre-
sponding to each class of prioritization with relative overlap
between classes is available in Table 1.
Random Forests
Carried out using the R package randomForests [51] with the
following non-default settings: 10,000 trees, 5,000 iterations, and
importance=TRUE. Input data comprised all SNPs with a non-
zero variance. Total input SNPs numbered 267,196 yielding 6322
‘‘important’’ SNPs for further analysis.
Association and locus analysis. These analyses were
carried out using plink v1.06 [52]; baseline settings were
employed for inclusion of probes and quality control.
(genotyping rate$80%, pruning of probes based on missingness
(GENO$1) and low frequency (MAF#0) as well as the removal of
heterozygous haploid genotypes (4545 found and removed from
analysis in this dataset). Total genotyping rate across all individuals
(66 cases, 830 controls) was 0.98, and after all pruning the initial
probe number (from which all described priority and GWAS
probes were drawn) was 311,399. Primary analysis of all priority
sets (as well as GWAS) was conducted using the same set of
covariates and phenotype definitions for each set. Full plink
settings for each run were ‘‘—logistic –adjust –qq-plot –sex’’ with
the requisite additional commands for selecting input and output
files. Logistic analysis is indicated for the discrete disease trait
(BAV/no-BAV) and the covariate adjustment is included for
gender and, ultimately, for returned p-values relative to number of
tests performed. Lack of deep phenotype information for control
population limits the ability to create more extensive covariate
controls in this population.
Supporting Information
Table S1 Frequency of major gene ontology classes present in
the combined prioritized gene lists returned by CANDID and
STRING. Frequency counts and fractional percentage relative to
total number of observations. Pathway members lacking more
specific annotations return the generic ‘‘biological_process’’
heading.
Found at: doi:10.1371/journal.pone.0008830.s001 (0.04 MB
PDF)
Table S2 Haplotype Analysis for BAT2/3. ‘‘|’’ indicates
haplotype grouped with one above it. Numbers in parenthesis
represent 95% confidence interval. OR (A), OR (U) Odds Ratio
Affected and Unaffected, respectively. Freq A, U, and P observed
haplotype frequency Affected, Unaffected, and Population (control
and experimental, this study); PS=Peptide Shift (in this case a
conservative instance), italics bases within haplotype signify
presence of peptide-shifting variant.
Found at: doi:10.1371/journal.pone.0008830.s002 (0.04 MB
PDF)
Table S3 Lowest observed significant corrected p-Values by
prioritization category. Lowest corrected p-Value observed at SNP
is bolded; NP=Not Present in group.
Found at: doi:10.1371/journal.pone.0008830.s003 (0.04 MB
PDF)
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